risedronic acid has been researched along with Innate Inflammatory Response in 6 studies
Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "High lung deposition and bioavailability of RIS was monitored with 88." | 1.72 | Nebulization of risedronate alleviates airway obstruction and inflammation of chronic obstructive pulmonary diseases via suppressing prenylation-dependent RAS/ERK/NF-κB and RhoA/ROCK1/MLCP signaling. ( Cao, J; Chen, H; Chen, R; Liu, D; Su, B; Tang, Y; Wu, D; Xu, J; Xu, W, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Abdou, WM | 1 |
| Ganoub, NA | 1 |
| Geronikaki, A | 1 |
| Sabry, E | 1 |
| Liu, D | 1 |
| Xu, W | 1 |
| Tang, Y | 1 |
| Cao, J | 1 |
| Chen, R | 1 |
| Wu, D | 1 |
| Chen, H | 1 |
| Su, B | 1 |
| Xu, J | 1 |
| Chehade, LK | 1 |
| Curragh, D | 1 |
| Selva, D | 1 |
| Luckish, A | 1 |
| Cernes, R | 1 |
| Boaz, M | 1 |
| Gavish, D | 1 |
| Matas, Z | 1 |
| Fux, A | 1 |
| Shargorodsky, M | 1 |
| Hemmati, I | 1 |
| Wade, J | 1 |
| Kelsall, J | 1 |
| Carvalho, AP | 1 |
| Bezerra, MM | 1 |
| Girão, VC | 1 |
| Cunha, FQ | 1 |
| Rocha, FA | 1 |
1 review available for risedronic acid and Innate Inflammatory Response
| Article | Year |
|---|---|
Risedronate-associated scleritis: a case report and review of the literature.
Topics: Adrenal Cortex Hormones; Aged; Brain; China; Diphosphonates; Etidronic Acid; Female; Humans; Inflamm | 2012 |
1 trial available for risedronic acid and Innate Inflammatory Response
| Article | Year |
|---|---|
Effect of long-term treatment with risedronate on arterial compliance in osteoporotic patients with cardiovascular risk factors.
Topics: Aged; Arteries; Biomarkers; Bone Density Conservation Agents; Cardiovascular Diseases; Compliance; D | 2008 |
4 other studies available for risedronic acid and Innate Inflammatory Response
| Article | Year |
|---|---|
Synthesis, properties, and perspectives of gem-diphosphono substituted-thiazoles.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bone Density Conservation Agents; Bone Resorption; | 2008 |
Nebulization of risedronate alleviates airway obstruction and inflammation of chronic obstructive pulmonary diseases via suppressing prenylation-dependent RAS/ERK/NF-κB and RhoA/ROCK1/MLCP signaling.
Topics: Airway Obstruction; Animals; Inflammation; Lung; Mice; NF-kappa B; Prenylation; Pulmonary Disease, C | 2022 |
Bisphosphonate-induced orbital inflammation: more common than once thought?
Topics: Aged; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Inflammation; Magnetic Reson | 2019 |
Anti-inflammatory and anti-nociceptive activity of risedronate in experimental pain models in rats and mice.
Topics: Acetic Acid; Analgesics; Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Diphosphonates; | 2006 |